Literature DB >> 316414

Human thymus cells: a study of rosette-forming capacity with unsensitized and sensitized erythrocytes of various species.

T Han, P Diegelman, S Subramanian, J Minowada.   

Abstract

Human thymus cells from 117 donors aged 2 months to 15 years, were studied for rosette-forming capacity with unsensitized and sensitized erythrocytes of various species. Viability of the thymus cells at the completion of isolation ranged from 95 to 99%. Over 90% of the total population of thymus cells were identified as T lymphocytes by either standard Es-rosette assay utilizing a 4 degree incubation with preceding centrifugation or T--LCL assay, on the average. Gravity Es-rosette assay high affinity Es-rosette assay, stable Es-rosette assay or active Es-rosette assay for identification of subsets of T lymphocytes indicate that most of the human thymus cells were capable of forming rosettes with unsensitized sheep erythrocytes at higher degrees of temperature with or without preceding centrifugation. Approximately half of the human thymus cells were also capable of forming rosettes with unsensitized allogeneic erythrocytes. Less than 3% of the thymus cells expressed receptors for the Fc portion of IgG (T gamma suppressor cells) whereas less than 1% of thymus cells expressed receptors for the Fc portion of IgM (T mu helper cells), indicating that most of the thymus cells are non-T mu/non T gamma cells. Only 1% or less of the thymus cells were identified as B cells by the SIg assay, the Em-rosette assay or the Ia-like antigen assay. There was no significant difference of any rosette assay between males and females or among various age groups.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 316414      PMCID: PMC1457830     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  20 in total

1.  Analysis of human thymocyte subpopulations using discontinuous gradients of albumin: precursor lymphocytes in human thymus.

Authors:  J G Gatien; E E Schneeberger; E Merler
Journal:  Eur J Immunol       Date:  1975-05       Impact factor: 5.532

2.  Active E rosette formation by human lymphoblasts.

Authors:  G Semenzato; G Amadori; P Sarasin; G Gasparotto
Journal:  Immunology       Date:  1978-04       Impact factor: 7.397

3.  Correlation of surface markers of cells of human lymphatic leukemias with disease type.

Authors:  T Tsubota; J Minowada; S Nakazawa; L F Sinks; T Han; R J Higby; D Pressman
Journal:  J Natl Cancer Inst       Date:  1977-09       Impact factor: 13.506

4.  Human T lymphocyte subpopulations: correlation between E-rosette-forming affinity and expression of the Fc receptor.

Authors:  W H West; S M Payne; J L Weese; R B Herberman
Journal:  J Immunol       Date:  1977-08       Impact factor: 5.422

5.  Subpopulations of human T lymphocytes. III. Distribution and quantitation in peripheral blood, cord blood, tonsils, bone marrow, thymus, lymph nodes, and spleen.

Authors:  S Gupta; R A Good
Journal:  Cell Immunol       Date:  1978-03-15       Impact factor: 4.868

6.  The T cell dependence of B cell differentiation induced by pokeweed mitogen.

Authors:  R G Keightley; M D Cooper; A R Lawton
Journal:  J Immunol       Date:  1976-11       Impact factor: 5.422

7.  Subpopulations of human T cells identified by receptors for immunoglobulins and mitogen responsiveness.

Authors:  L Moretta; M Ferrarini; M C Mingari; A Moretta; S R Webb
Journal:  J Immunol       Date:  1976-12       Impact factor: 5.422

8.  Human autologous and allogeneic rosettes.

Authors:  M Lambermont; J Wybran; A Govaerts
Journal:  J Immunol Methods       Date:  1977       Impact factor: 2.303

9.  Human thymus cells: blastogenic response to mitogens, antigens and allogeneic cells.

Authors:  T Han; J Minowada; S Subramanian; L F Sinks
Journal:  Immunology       Date:  1976-10       Impact factor: 7.397

10.  Functional analysis of two human T-cell subpopulations: help and suppression of B-cell responses by T cells bearing receptors for IgM or IgG.

Authors:  L Moretta; S R Webb; C E Grossi; P M Lydyard; M D Cooper
Journal:  J Exp Med       Date:  1977-07-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.